desmopressin acetate
Generic: desmopressin acetate
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
desmopressin acetate
Generic Name
desmopressin acetate
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
desmopressin acetate 4 ug/mL
Manufacturer
Identifiers & Regulatory
Product NDC
65219-295
Product ID
65219-295_499d7fa7-43ab-47f0-ae4b-0f9791745f14
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA216904
Listing Expiration
2026-12-31
Marketing Start
2023-09-11
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65219295
Hyphenated Format
65219-295
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
desmopressin acetate (source: ndc)
Generic Name
desmopressin acetate (source: ndc)
Application Number
ANDA216904 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 4 ug/mL
Packaging
- 1 VIAL, MULTI-DOSE in 1 CARTON (65219-295-10) / 10 mL in 1 VIAL, MULTI-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "499d7fa7-43ab-47f0-ae4b-0f9791745f14", "openfda": {"unii": ["XB13HYU18U"], "rxcui": ["849501"], "spl_set_id": ["9725ba8e-ac0f-4655-bb98-9ea926142815"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (65219-295-10) / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "65219-295-10", "marketing_start_date": "20230911"}], "brand_name": "Desmopressin Acetate", "product_id": "65219-295_499d7fa7-43ab-47f0-ae4b-0f9791745f14", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Factor VIII Activator [EPC]", "Increased Coagulation Factor VIII Activity [PE]", "Increased Coagulation Factor VIII Concentration [PE]", "Vasopressin Analog [EPC]", "Vasopressins [CS]"], "product_ndc": "65219-295", "generic_name": "Desmopressin Acetate", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Desmopressin Acetate", "active_ingredients": [{"name": "DESMOPRESSIN ACETATE", "strength": "4 ug/mL"}], "application_number": "ANDA216904", "marketing_category": "ANDA", "marketing_start_date": "20230911", "listing_expiration_date": "20261231"}